What is MOSS?
MOSS Inc. stands as a cornerstone in the biotechnology supply chain, specializing in the production of high-quality, liquid-stable immunoassay reagents. For over 34 years, the company has provided critical substrates and conjugates to the diagnostics, pharma, and veterinary sectors. Operating under strict ISO-9001-2015 guidelines, MOSS Inc. distinguishes itself through exceptional sensitivity and lot-to-lot consistency, offering custom services that span from initial assay development to large-scale bulk manufacturing. Their commitment to product stability, with most offerings maintaining integrity for over 36 months, has solidified their reputation as a trusted partner for leading manufacturers and distributors worldwide.
The company's business model is built upon the intersection of technical precision and industrial scalability. By focusing on the foundational elements of diagnostic testing, MOSS Inc. serves as an essential infrastructure provider for the broader healthcare and research ecosystem. Their ability to maintain rigorous quality control while scaling production for global distribution highlights their operational maturity and competitive advantage in a highly regulated industry.
How much funding has MOSS raised?
MOSS has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MOSS
PPP
Public-Private Partnership
What's next for MOSS?
With this recent infusion of capital, MOSS Inc. is poised to accelerate its strategic growth initiatives. The company is expected to focus on expanding its manufacturing capacity to accommodate the increasing global demand for reliable diagnostic reagents. Furthermore, the investment will likely support the enhancement of their custom service offerings, allowing for deeper integration into the R&D pipelines of pharmaceutical and biotechnology clients. As the diagnostic landscape continues to prioritize speed and accuracy, MOSS Inc. remains committed to maintaining its high standards of stability and performance, ensuring that its long-term trajectory remains aligned with the needs of the global scientific community.
See full MOSS company page
